Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Positive Advanced Gastric Cancer × Tissue Banks × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 3 Uterine Cervical Neoplasms 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasm Metastasis 1 Hepatoblastoma 1 HER2 Positive Advanced Gastric Cancer 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Carcinosarcoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05348161 2022-04-27

Dynamic Multiomics Evaluation of Anti-HER2 and Immunotherapy in HER2 Positive Gastric Cancer

Peking University

Phase NA Unknown

Gastrointestinal

HER2 Positive Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡